Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1016795

Active fusions of Cas9 orthologs


Josipović, Goran; Zoldoš, Vlatka; Vojta, Aleksandar
Active fusions of Cas9 orthologs // Journal of biotechnology, 301 (2019), 18-23 doi:10.1016/j.jbiotec.2019.05.306 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1016795 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Active fusions of Cas9 orthologs

Autori
Josipović, Goran ; Zoldoš, Vlatka ; Vojta, Aleksandar

Izvornik
Journal of biotechnology (0168-1656) 301 (2019); 18-23

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Cas9 ortholog ; Cas9 fusion ; sgRNA ; DNMT3A ; Epigenome editing

Sažetak
Many recent epigenetic studies utilize the advantages of CRISPR/dCas9 based tools in linking certain epigenetic modification with gene expression regulation. Various multifactorial diseases often contain changed epigenetic signatures at many loci, so tools for simultaneously targeting different loci would significantly facilitate the understanding of disease pathogenesis. We tested different dCas9 orthologs (dCjCas9, dNmCas9, dSt1Cas9, dFnCas9, dSaCas9 and dSpCas9) in C-terminal fusion with DNMT3A effector domain to find candidates that potentiate effector domain to perform its function at the target site. We demonstrated that nuclear localization signals (NLS) at both termini of fusion constructs is crucial for both proper nuclear import of such large constructs as well as for maximization of targeted DNA methylation activity. We identified SpCas9, SaCas9 and CjCas9 as potential candidates for the fusion constructs. With further optimization of the SaCas9 ortholog, due to less complex PAM requirements in contrast to CjCas9, we showed that N-terminal fusion with DNMT3A (dSaCas9- DNMT3A) is optimal to exert targeted DNA methylation activity comparable to the dSpCas9- DNMT3A construct. N-terminal fusions showed better results for both Cas9 orthologs, SaCas9 and SpCas9, so it can be used as universal approach for linking different effector domains in order to obtain highly active fusions.

Izvorni jezik
Engleski

Znanstvena područja
Biologija, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)



POVEZANOST RADA


Ustanove:
Prirodoslovno-matematički fakultet, Zagreb

Profili:

Avatar Url Goran Josipović (autor)

Avatar Url Vlatka Zoldoš (autor)

Avatar Url Aleksandar Vojta (autor)

Poveznice na cjeloviti tekst rada:

doi www.sciencedirect.com

Citiraj ovu publikaciju:

Josipović, Goran; Zoldoš, Vlatka; Vojta, Aleksandar
Active fusions of Cas9 orthologs // Journal of biotechnology, 301 (2019), 18-23 doi:10.1016/j.jbiotec.2019.05.306 (međunarodna recenzija, članak, znanstveni)
Josipović, G., Zoldoš, V. & Vojta, A. (2019) Active fusions of Cas9 orthologs. Journal of biotechnology, 301, 18-23 doi:10.1016/j.jbiotec.2019.05.306.
@article{article, author = {Josipovi\'{c}, Goran and Zoldo\v{s}, Vlatka and Vojta, Aleksandar}, year = {2019}, pages = {18-23}, DOI = {10.1016/j.jbiotec.2019.05.306}, keywords = {Cas9 ortholog, Cas9 fusion, sgRNA, DNMT3A, Epigenome editing}, journal = {Journal of biotechnology}, doi = {10.1016/j.jbiotec.2019.05.306}, volume = {301}, issn = {0168-1656}, title = {Active fusions of Cas9 orthologs}, keyword = {Cas9 ortholog, Cas9 fusion, sgRNA, DNMT3A, Epigenome editing} }
@article{article, author = {Josipovi\'{c}, Goran and Zoldo\v{s}, Vlatka and Vojta, Aleksandar}, year = {2019}, pages = {18-23}, DOI = {10.1016/j.jbiotec.2019.05.306}, keywords = {Cas9 ortholog, Cas9 fusion, sgRNA, DNMT3A, Epigenome editing}, journal = {Journal of biotechnology}, doi = {10.1016/j.jbiotec.2019.05.306}, volume = {301}, issn = {0168-1656}, title = {Active fusions of Cas9 orthologs}, keyword = {Cas9 ortholog, Cas9 fusion, sgRNA, DNMT3A, Epigenome editing} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font